| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on May 7, 2009
Accepted on August 21, 2009
From the Department of Molecular Pathology (T.K., Y.Y., Y.L., A.B.W., N.S., T.I., Y.W., J.F.), Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Japan; the Analytical Research Center for Experimental Sciences (S.K., K.N.), Saga University, Japan; the Laboratory Animal Center (E.L.), Xi'an Jiaotong University School of Medicine, China; the Department of Pharmacology (H.S.), Dalian Medical University, China; the Department of Cardiology (B.Z., K.S.), Fukuoka University School of Medicine, Japan; the Department of Lipidology (J.K.), Kanazawa University Graduate School of Medical Science, Ishikawa, Japan; the Department of Rehabilitation (M.M.), Kumamoto Health Science University, Kumamoto, Japan; and the Fukuoka Wajiro Hospital (T.W.), Fukuoka, Japan.
* To whom correspondence should be addressed. E-mail: fan_molpatho{at}yahoo.co.jp.
Objective—Apolipoprotein AII (apoAII) is the second major apolipoprotein in high-density lipoprotein (HDL). However, the physiological functions of apoAII in lipoprotein metabolism have not been fully elucidated.
Methods and Results—We generated human apoAII transgenic (Tg) rabbits, a species that normally does not have an endogenous apoAII gene. Plasma levels of human apoAII in Tg rabbits were
30 mg/dL, similar to the plasma levels in healthy humans. The expression of human apoAII in Tg rabbits resulted in increased levels of plasma triglycerides, total cholesterol, and phospholipids accompanied by a marked reduction in HDL-cholesterol levels compared with non-Tg littermates. Analysis of lipoprotein fractions showed that hyperlipidemia exhibited by Tg rabbits was caused by elevated levels of very-low-density lipoproteins (VLDL) and intermediate-density lipoproteins. Furthermore, postheparin lipoprotein lipase activity significantly decreased in Tg rabbits compared with non-Tg rabbits.
Conclusions—These results indicate that apoAII plays an important role in both VLDL and HDL metabolism, possibly through the inhibition of lipoprotein lipase activity. ApoAII Tg rabbits may become a new model for the study of human familial combined hyperlipidemia.
Related Article:
Read all eLetters
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |